Reauthorization of FDA’s Rare Pediatric Disease Priority Review Voucher (PRV) program provides opportunity for Opus’ deep pipeline in rare inherited retinal diseases - - FDA Prescription Drug User Fee ...

Field-level, daily water use insights across 220,000 acres to support SGMA compliance and groundwater sustainability WASHINGTON, DC / ACCESS Newswire / March 10, 2026 / Hydrosat, the leading provider ...